LUMEXA IMAGING HOLDINGS INC (LMRI) Stock Price & Overview
NASDAQ:LMRI • US5502491062
The current stock price of LMRI is 14.45 USD. Today LMRI is down by -1.9%. In the past month the price increased by 25.11%.
LMRI Key Statistics
- Market Cap
- 1.367B
- P/E
- N/A
- Fwd P/E
- 18.04
- EPS (TTM)
- -1.00
- Dividend Yield
- N/A
LMRI Stock Performance
LMRI Stock Chart
LMRI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to LMRI.
LMRI Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to LMRI. LMRI may be in some trouble as it scores bad on both profitability and health.
LMRI Earnings
LMRI Forecast & Estimates
12 analysts have analysed LMRI and the average price target is 23.05 USD. This implies a price increase of 59.53% is expected in the next year compared to the current price of 14.45.
For the next year, analysts expect an EPS growth of 101.44% and a revenue growth 9.29% for LMRI
LMRI Groups
Sector & Classification
LMRI Financial Highlights
Over the last trailing twelve months LMRI reported a non-GAAP Earnings per Share(EPS) of -1. The EPS increased by 23.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.57% | ||
| ROE | -56.31% | ||
| Debt/Equity | 7.19 |
LMRI Ownership
LMRI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.52 | 99.563B | ||
| CI | THE CIGNA GROUP | 8.39 | 71.045B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 100.01 | 26.976B | ||
| LH | LABCORP HOLDINGS INC | 14.92 | 22.682B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.71 | 22.148B | ||
| GH | GUARDANT HEALTH INC | N/A | 11.75B | ||
| DVA | DAVITA INC | 10.72 | 10.191B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.81 | 8.173B | ||
| CHE | CHEMED CORP | 16.53 | 5.556B | ||
| HIMS | HIMS & HERS HEALTH INC | 42.98 | 5.051B | ||
| RDNT | RADNET INC | 76.46 | 4.824B | ||
| OPCH | OPTION CARE HEALTH INC | 15.52 | 4.642B | ||
| HNGE | HINGE HEALTH INC-A | 23.81 | 3.62B |
Related stock screener links
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LMRI
Company Profile
Lumexa Imaging Holdings, Inc. engages in providing diagnostic imaging services. The company is headquartered in Raleigh, North Carolina and currently employs 4,064 full-time employees. The company went IPO on 2025-12-11. The firm offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The firm and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.
Company Info
IPO: 2025-12-11
LUMEXA IMAGING HOLDINGS INC
4200 Six Forks Road, Suite 1000
Raleigh NORTH CAROLINA US
Employees: 4064
Phone: 19197631100
LUMEXA IMAGING HOLDINGS INC / LMRI FAQ
What does LMRI do?
Lumexa Imaging Holdings, Inc. engages in providing diagnostic imaging services. The company is headquartered in Raleigh, North Carolina and currently employs 4,064 full-time employees. The company went IPO on 2025-12-11. The firm offers a range of advanced imaging services (MRI, CT and PET scans) and routine diagnostic and screening imaging services (X-ray, ultrasound and mammography). The Company’s segments include Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The Outpatient segment consists of imaging centers that are owned or operated by it (either wholly owned or via unconsolidated affiliate), where it performs the imaging scan and provides the radiologist’s interpretation service. The Professional segment consists of professional interpretation services, where the imaging scan itself is performed at the hospital or point of care and not by it or its unconsolidated affiliates. The firm and its affiliates operate outpatient imaging center footprint in the United States, spanning 184 centers across 13 states and includes eight joint venture partnerships with health systems.
What is the current price of LMRI stock?
The current stock price of LMRI is 14.45 USD. The price decreased by -1.9% in the last trading session.
What is the dividend status of LUMEXA IMAGING HOLDINGS INC?
LMRI does not pay a dividend.
What is the ChartMill rating of LUMEXA IMAGING HOLDINGS INC stock?
LMRI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is LUMEXA IMAGING HOLDINGS INC (LMRI) stock traded?
LMRI stock is listed on the Nasdaq exchange.
How is the valuation of LUMEXA IMAGING HOLDINGS INC (LMRI) based on its PE ratio?
LUMEXA IMAGING HOLDINGS INC (LMRI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1).
What is the expected growth for LMRI stock?
The Revenue of LUMEXA IMAGING HOLDINGS INC (LMRI) is expected to grow by 9.29% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.